Abstract This review assesses whether the risk of ileoanal pouch construction in patients with ulcerative colitis, compared with that of βless dangerousβ operations, is compensated by a better postoperative outcome. Even though the mortality rate is not greater for pouch construction, the risk of pe
Treatment of suicidal patients: A risk-benefit analysis
β Scribed by James C. Overholser
- Publisher
- John Wiley and Sons
- Year
- 1995
- Tongue
- English
- Weight
- 873 KB
- Volume
- 13
- Category
- Article
- ISSN
- 0735-3936
No coin nor oath required. For personal study only.
β¦ Synopsis
A therapist may be held liable when a patient commits suicide if previous suicidal tendencies were observed but reasonable precautions were not taken. In order to reduce liability and enhance treatment effectiveness, therapeutic decisions can be critiqued by estimating the risks and benefits associated with different courses of action. A n evaiuation of risks and benefits can be used to guide decisions regarding assessment, hospitalization, medications, and discharge fkom the hospital. A risk-benefit analysis can help therapists utilize a broad range of treatment options while allowing patients the maximum degree of autonomy. Additionally, all aspects of treatment should be well documented, including information about the specific course of action chosen, other treatment options considered, and the therapeutic rationale for deciding which treatment plan was best suited to the patient's needs.
π SIMILAR VOLUMES
T he role of postmastectomy adjuvant radiation in the treatment of operable breast carcinoma remains controversial. Although multiple prospective randomized trials have demonstrated the ability of radiation to decrease the incidence of locoregional recurrence, the absence of a decrease in distant me
W e thank Dr. Fowble for her detailed, analytic editorial highlighting of our article, ''The Role of Radiotherapy in the Management of Operable Locally Advanced Breast Carcinoma: Results of a Randomized Trial by the Eastern Cooperative Oncology Group.'' Dr. Fowble's reaction to our report on the Eas